Aker BioMarine
Norwegian krill oil company controlling its supply chain from harvesting through processing.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Aker BioMarine is a Norwegian biotech company that develops krill-derived products for consumer health and nutrition. Founded in 2006 and headquartered in Lysaker, Norway, the company is publicly traded on the Oslo Stock Exchange (AKBM). Their flagship ingredient brand, Superba Krill, provides omega-3 fatty acids (EPA and DHA) in phospholipid form along with choline and the antioxidant astaxanthin. Aker BioMarine controls the full supply chain from Antarctic krill harvesting through proprietary processing technology. The company operates one of the most vertically integrated omega-3 supply chains in the industry.
Certifications
Certification verification in progress. International supplier records require regional database lookups (EudraGMDP, Health Canada NHP, FSSC public register, JHFA directory). See our methodology.
Capabilities
- PRODUCT TYPES
- Krill Oil (Superba Brand) · Omega-3 Phospholipids · Choline · Astaxanthin (from Krill)
- CAPABILITIES
- Branded or patented ingredients · Clinical research or study support · Omega-3s or specialty oils · Traceable or vertically integrated supply · Sustainability programs
Sources
- Aker BioMarine Official Website(2026-04-02)
- Aker BioMarine Wikipedia — company history and operations(2026-04-02)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Headquarters and primary operations in Norway
- Krill-focused. Does not supply fish oil or plant-based omega-3 alternatives
- Certification details beyond cGMP not independently verified from public databases
- Previously associated with Epax (fish oil concentrates) but divested in 2010; they are now separate companies
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between Aker BioMarine and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in Aker BioMarine?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.